| Título: | Association between Genetic Polymorphism of Methylenetetrahydrofolate Reductase with Non Familial Colorectal Cancer in Iranian Population |
| Autores: |
Montazer Haghighi, M Radpour, R Vahedi, M Mohebbi, SR Khatami, F Derakhshan, F Atarian, H Zali, MR |
| Fecha: | 2012-04-21 |
| Publicador: | Shahid Beheshti University of Medical Sciences |
| Fuente: |
Ver documento |
| Tipo: |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| Tema: | No aplica |
| Descripción: | Abstract: Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating folate metabolism, which affects DNA methylation and synthesis. One of the most important polymorphisms identified in the MTHFR gene is C677T. MTHFR activity is lowered in individuals with 677TT genotype.Using pyrosequencing, we analyzed the MTHFR genotypes in 118 colorectal cancer patients and 189 normal matched controls. Whereas the CC, CT and TT genotypes of MTHFR among the colorectal cancer patients were 51.7%, 28.0 % and 20.3% respectively, we were able to find 47.1% of 677CC, 27.0% of 677CT and 25.9% of 677TT in normal controls. An inverse association was observed between the risk of colorectal cancer and TT genotype with the odds ratios (OR) of 1, 0.94 and 0.71 for CC, CT, and TT genotypes, respectively. This association was similar in both sexes, but in patients with high levels of folate intake. Our study corroborates previous findings of an inverse association between MTHFR 677TT genotype and colorectal cancer, especially at high levels of folate.Keywords: Non familial colorectal cancer, methylenetetrahydrofolate reductase, pyrosequencing, polymorphism1. Kono S , Chen K .Genetic polymorphisms ofmethylenetetrahydrofolate reductase and colorectal cancerand adenoma .Cancer Science. 2005; 96:535-542.2. Fearon ER, Vogelstein BA . A genetic model forcolorectal tumorigenesis. Cell 1990;61:759-767.3. Issa JP, Ottaviano YL, Celano P, Hamilton SR,Davidson NE, Baylin SB Methylation of the oestrogenreceptor CpG island links aging and neoplasia in humancolon. Nat Genet. 1994;7:536-540.4. Warnecke PM, Bestor TH .Cytosine methylation andhuman cancer. Curr Opin Oncol. 2000 ; 12: 68–73.5. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reducedgenomic 5-methylcytosine content in human colonicneoplasia. Cancer Res. 1988; 48: 1159–1161.6. Ballestar E, Esteller M . The impact of chromatin inhuman cancer: linking DNA methylation to gene silencing.Carcinogenesis. 2002; 23: 1103–1109.7. Blount BC, Mack MM, Wehr CM . Folate deficiencycauses uracil misincorporation into human DNA andchromosome breakage: implications for cancer and neuronaldamage. Proc Natl Acad Sci USA.1997; 94: 3290–3295.8. Duthie SJ . Folic acid deficiency and cancer: mechanismsof DNA instability. Br Med Bull 1999 ;55: 578–592.9. Frosst P, Blom HJ, Milos R . A candidate genetic riskfactor for vascular disease: a common mutation inmethylenetetrahydrofolate reductase. Nat Genet. 1995; 10:111–3.10. Deloughery TG, Evans A, Sadeghi A. Commonmutation in methylenetetrahydrofolate reductase. Correlationwith homocysteine metabolism and late-onset vasculardisease.Circulation 1996; 94:3074–3078.11. Ma J, Stampfer MJ, Hennekens CH.Methylenetetrahydrofolate reductase polymorphism, plasmafolate, homocysteine, and risk of myocardial infarction in USphysicians. Circulation .1996;94: 2410–2416.12. Harmon DL, Woodside JV, Yarnell JW. The common“thermolabile” variant of methylene tetrahydrofolatereductase is a major determinant of mildhyperhomocysteinaemia. Q J Med.1996; 89:571–577.13. Malinow MR, Nieto FJ, Kruger WD, et al The effectsof folic acid supplementation on plasma total homocysteineare modulated by multivitamin use andmethylenetetrahydrofolate reductase genotypes. ArteriosclerThromb Vasc Biol.1997; 17:1157–1162.14. Hoffbrand AV, Newcombe FA, Mollin DL. Method ofassay of red cell folate activity and the value of the assay asa test for folate deficiency. J Clin Pathol .1996;19:17–28.15. Mostafa Ronaghi. Pyrosequencing Sheds Light onDNA Sequencing .Genome Research. 2001; 11: 3-11.16. Langaee T, Ronaghi M. Genetic variation analyses byPyrosequencing. Mutat Res. 2005 ; 3:96-102.17. Chen J, Giovannucci E, Hankinson SE. A prospectivestudy of methylenetetrahydrofolate reductase andmethionine synthase gene polymorphisms, and risk ofcolorectal adenoma. Carcinogenesis 1998; 19: 2129–2132.18. Ulrich CM, Kampman E, Bigler J. Colorectaladenomas and the C677T MTHFR polymorphism: evidencefor gene–environment interaction? Cancer EpidemiolBiomarkers Prev. 1999; 8: 659–68.19. Levine AJ, Siegmund KD, Ervin CM. Themethylenetetrahydrofolate reductase 677C > Tpolymorphism and distal colorectal adenoma risk. CancerEpidemiol Biomarkers Prev 2000; 9: 657–663.20. Giovannucci E, Chen J, Smith-Warner SA.Methylenetetrahydrofolate reductase, alcoholdehydrogenase, diet, and risk of colorectal adenomas.Cancer Epidemiol Biomarkers Prev 2003; 12: 970–979.21. Delgado-Enciso I, Martinez-Garza SG, Rojas-Martinez A. 677T mutation of the MTHFR gene in adenomasand colorectal cancer in a population sample from theNortheastern Mexico. Rev Gastroenterol Mex. 2001; 66:32–7.22. Sachse C, Smith G, Wilkie MJ . A pharmacogeneticstudy to investigate the role of dietary carcinogens in theetiology of colorectal cancer. Carcinogenesis .2002; 23:1839–1849.23. Marugame T, Tsuji E, Inoue H.Methylenetetrahydrofolate reductase polymorphism and riskof colorectal adenomas. Cancer Lett .2000; 151: 181–186.24. Hirose M, Kono S, Tabata S . Genetic polymorphismsof methylenetetrahydrofolate reductase and aldehydedehydrogenase, alcohol use and risk of colorectaladenomas: Self-Defense Forces Health Study. Cancer Sci.2005; 96: 513–518.25. Ulvik A, Evensen ET, Lien EA . Smoking, folate andmethylenetetrahydrofolate reductase status as interactivedeterminants of adenomatous and hyperplastic polyps ofcolorectum. Am J Med Genet 2001; 101: 246–254.26. Sachse C, Smith G, Wilkie MJ . A pharmacogeneticstudy to investigate the role of dietary carcinogens in theetiology of colorectal cancer. Carcinogenesis .2002; 23:1839–1849.27. Plaschke J, Schwanebeck U, Pistorius S, Saeger HD,Schackert HK. Methylenetetrahydrofolate reductasepolymorphisms and risk of sporadic and hereditarycolorectal cancer with or without microsatellite instability.Cancer Lett 2003; 191: 179–185.28. Shannon B, Gnanasampanthan S, Beilby J, IacopettaB. A polymorphism in the methylenetetrahydrofolatereductase gene predisposes to colorectal cancers withmicrosatellite instability. Gut 2002; 50: 520–524.29. Matsuo K, Hamajima N, Hirai T . Methionine synthasereductase gene A66G polymorphism is associated with riskof colorectal cancer. Asian Pac J Cancer Prev .2002; 3:353–359.30. Ma J, Stampfer MJ, Giovannucci E.Methylenetetrahydrofolate reductase polymorphism, dietaryinteractions and risk of colorectal cancer. Cancer Res1997;57: 1098–1102.31. Weisberg I, Tran P, Christensen B, Sibani R, Rozen R.A second polymorphism in methylenetetrahydrofolatereductase (MTHFR) associated with decreased enzymeactivity. Mol Genet Metab 1998; 64:169–172.32. Deloughery TG, Evans A, Sadeghi A. Commonmutation in methylenetetrahydrofolate reductase. Correlationwith homocysteine metabolism and late-onset vasculardisease. Circulation 1996; 94:3074–3078.33. Poirier L, Wise C, Delongchamp R, Sinha R .Blooddeterminations of S-adenosylmethionine. Sadenosylhomocysteine,and homocysteine: correlations withdiet. Cancer Epidemiol Biomark Prev 2002; 10:649–655 |
| Idioma: | Inglés |
1 Health and Education - 2 por Akbari, Mohammad Esmaeil | 6 Effectiveness of Mindfulness-Based Cognitive Therapy on Reduction of Depression and Anxiety Symptoms in Mothers of Children With Cancer por Mehranfar, Mojtaba; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Younesi, Jalal; Dept. of Counselling, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran,Banihashem, Abdollah; Dept. of Internal Medicine and Paediatrics, University of
Medical Sciences, Mashhad, Iran |
2 The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines por Alipour, Mohsen; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Zargar, Seyed Jalal; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Safarian, Shahrokh; Dept. of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran,Fouladdel, Shamile; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran,Azizi, Ebrahim; Dept. of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran,Jafargholizadeh, Naser; Dept. of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran | 7 Prevention and Management of Mucositis in Patients With Cancer: a Review Article por [wlia, ّatemeh; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,«azemeini, ُeidkazem; Burn hospital, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran,gholami, neda; Dept. of Oral Medicine, Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran |
3 Cancer Prevention; Cancer Risk Management por Akbari, Mohammad Esmaeil | 8 Psychosocial Care for Breast Cancer: Physicians' Perspective por Kaviani, Ahmad; Department of surgery, Tehran University of Medical Sciences, Tehran, Iran,Mehrdad, N; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Yunesian, M; school of Public Health , Environmental Research Center, Tehran University of Medical Sciences, Tehran, Iran,Shakiba, B; Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran,Ebrahimi, M; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Majidzadeh, K; Iranian Center for Breast Cancer (ICBC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
4 Euthanasia in Cancer Patients, Islamic Point of View por Mousavi, SM; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, A; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Akbari, ME; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Najd Sepas, H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 9 Cell Survival Entropy and Cellular Resistance Activation Dose: Effect of Calprotectin on Gastric Adenocarcinoma Cell Line por Rezaei-Tavirani, Mostafa,Rahmati-Roodsari, Mohammad,Mirzaie, Mehdi,Amini Geram, Pooneh,Sobhi, Sara |
5 Evaluation of Prognostic Factors In Patients with Metastatic Breast Cancer por Saeidi Saedi, H,Seilanian Toosi, M,Mirsadraei, M,Roodbari, S | 10 Antiphospholipid Antibodies in Neoplastic Patients por Mortazavizadeh, MR,Sadeghmanesh, R |